Results 71 to 80 of about 312 (196)

Adult T‐cell leukemia/lymphoma in French Guiana (1990–2019): Epidemiology, clinical features, and HTLV‐1 genetic diversity in the two main ethnic populations

open access: yesInternational Journal of Cancer, Volume 158, Issue 6, Page 1528-1540, 15 March 2026.
What's new? Adult T‐cell leukemia/lymphoma (ATL) is a rare and aggressive malignancy caused by human T‐cell leukemia virus type 1 (HTLV‐1). The authors comprehensively analyzed the epidemiological and clinical features of ATL over a 30‐year period in French Guiana, a region with high HTLV‐1 endemicity and a multiethnic population.
Jill‐Léa Ramassamy   +16 more
wiley   +1 more source

L’impact de la COVID‐19 sur l’expérience client en magasin

open access: yesCanadian Journal of Administrative Sciences / Revue Canadienne des Sciences de l'Administration, Volume 43, Issue 1, March 2026.
ABSTRACT Customer experience, a key concept in marketing, consists of five dimensions (sensory, emotional, cognitive, behavioural and social) that can allow consumers to have a unique and pleasant experience. However, the COVID‐19 pandemic has significantly altered these dimensions and thus transformed the consumer's in‐store experience.
Samantha Langis, Isabelle Brun
wiley   +1 more source

Prevalence of Patients With Pain Consulting Physiotherapists (PHYSIODOL Survey). A Nationwide Survey in France

open access: yesEuropean Journal of Pain, Volume 30, Issue 3, March 2026.
ABSTRACT Background Pain, whether as a symptom or a chronic disease, is the leading cause of medical consultations but there is no data on whether this is also the case in the practice of physiotherapy. Objective To assess the prevalence of patients with pain consulting a physiotherapist in France.
Thibaut Mussigmann   +5 more
wiley   +1 more source

The European CAR‐T map—Current status and future directions to improve access to CAR T‐cell therapy for hematologic malignancies

open access: yesHemaSphere, Volume 10, Issue 3, March 2026.
Abstract Despite its great promise, implementation of CAR‐T therapy—a personalized, logistically complex, and expensive treatment—remains challenging, hampering patient access across and within countries. Since 2018, six products have been centrally approved in Europe (i.e., the European Economic Area; EU‐approved) for 15 hematologic malignancy ...
Elise R. A. Pennings   +22 more
wiley   +1 more source

Huntington's Disease and Huntington's Disease‐like 2 (HDL2) in Martinique

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 3, Page 673-682, March 2026.
ABSTRACT Background Huntington's Disease‐like 2 (HDL2), caused by a CAG repeat expansion in JPH3, closely resembles HD. All reported HDL2 patients to date have some African ancestry. While both disorders exist in the Caribbean, their relative frequency and clinical characteristics remain largely unknown.
Ignacio Antolin‐Sanfeliz   +8 more
wiley   +1 more source

Ocular Motor Abnormalities in Functional Neurological Disorder: A Video‐Oculography Study

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 3, Page 711-722, March 2026.
Abstract Background Functional neurological disorders (FND) can include various sensory, motor or cognitive symptoms. Eye movement recordings, measured through video‐oculography, could serve as biomarkers for characterizing these dysfunctions in FND.
Aude Sangare   +13 more
wiley   +1 more source

Egalitarians despite themselves: envy and leadership in Ecuadorian Amazonia Égalitaires malgré eux : envie et leadership en Amazonie équatorienne

open access: yesJournal of the Royal Anthropological Institute, Volume 32, Issue S1, Page 28-48, March 2026.
The Shuar of Ecuadorian Amazonia once pursued eminence through warfare and vision quests. While vision quests have been retained, today – settled in villages – they seek eminence through economic success and political leadership. This article examines an apparent paradox: whilst envy suspicions pervade public life, they legitimize rather than level ...
Natalia Buitron, Grégory Deshoullière
wiley   +1 more source

Home - About - Disclaimer - Privacy